- Home
- ZURA vs HYPR Comparison
ZURA vs HYPR Comparison
Compare ZURA & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- HYPR
- Stock Information
- Founded
- ZURA 2022
- HYPR 2014
- Country
- ZURA United States
- HYPR United States
- Employees
- ZURA N/A
- HYPR N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- HYPR Medical Specialities
- Sector
- ZURA Health Care
- HYPR Health Care
- Exchange
- ZURA Nasdaq
- HYPR Nasdaq
- Market Cap
- ZURA 137.2M
- HYPR 113.9M
- IPO Year
- ZURA N/A
- HYPR N/A
- Fundamental
- Price
- ZURA $4.16
- HYPR $1.64
- Analyst Decision
- ZURA Buy
- HYPR Strong Buy
- Analyst Count
- ZURA 9
- HYPR 3
- Target Price
- ZURA $11.00
- HYPR $1.28
- AVG Volume (30 Days)
- ZURA 3.9M
- HYPR 356.4K
- Earning Date
- ZURA 11-06-2025
- HYPR 11-11-2025
- Dividend Yield
- ZURA N/A
- HYPR N/A
- EPS Growth
- ZURA N/A
- HYPR N/A
- EPS
- ZURA N/A
- HYPR N/A
- Revenue
- ZURA N/A
- HYPR $10,797,000.00
- Revenue This Year
- ZURA N/A
- HYPR $12.92
- Revenue Next Year
- ZURA N/A
- HYPR $32.10
- P/E Ratio
- ZURA N/A
- HYPR N/A
- Revenue Growth
- ZURA N/A
- HYPR N/A
- 52 Week Low
- ZURA $0.97
- HYPR $0.53
- 52 Week High
- ZURA $5.07
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- ZURA 84.19
- HYPR 70.07
- Support Level
- ZURA $2.07
- HYPR $1.40
- Resistance Level
- ZURA $2.35
- HYPR $1.49
- Average True Range (ATR)
- ZURA 0.21
- HYPR 0.10
- MACD
- ZURA 0.20
- HYPR 0.01
- Stochastic Oscillator
- ZURA 95.42
- HYPR 97.10
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.